Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Oesophageal cancer, Stomach cancer
Closed
Phase 2
This study is looking at pembrolizumab for cancer of the foodpipe or cancer where the foodpipe meets the stomach (gastro oesophageal junction). It is for people who have already had 2 treatments since the cancer spread.
Recruitment start: 14 April 2016
Recruitment end: 31 October 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Daniel Hochhauser
Merck Sharp & Dohme Ltd
Last reviewed: 06 Dec 2016
CRUK internal database number: 14102